Post

Japan approves AstraZeneca’s Truqap with Faslodex for breast cancer

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved AstraZeneca's Truqap (capivasertib) plus Faslodex (fulvestrant) for a specific …

Which drugs are most likely to be approved in Non-infectious Uveitis?

Non-infectious Uveitis is an indication for drug development with over 10 pipeline drugs currently active. According to GlobalData, preregistered drugs …

Which drugs are most likely to be approved in Choroidal Disease?

Choroidal Disease is an indication for drug development with over 40 pipeline drugs currently active. According to GlobalData, preregistered drugs …

Which drugs are most likely to be approved in Bipolar I Disorder?

Bipolar I Disorder is an indication for drug development with over 7 pipeline drugs currently active. According to GlobalData, preregistered …

Which drugs are most likely to be approved in Mixed Pain (Nociceptive Pain/Neuropathic Pain)?

Mixed Pain (Nociceptive Pain/Neuropathic Pain) is an indication for drug development with over 270 pipeline drugs currently active. According to …